MCM
ABBV icon

M1 Capital Management’s AbbVie ABBV Stock Holding History

M1 Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Buy
1,769
+53
+3% +$11.4K 0.16% 74
2026
Q1 		$373K Buy
1,716
+44
+3% +$9.76K 0.17% 78
2025
Q4 		$382K Buy
1,672
+60
+4% +$13.7K 0.16% 79
2025
Q3 		$373K Buy
1,612
+135
+9% +$27.5K 0.16% 79
2025
Q2 		$274K Buy
1,477
+186
+14% +$34.6K 0.14% 86
2025
Q1 		$271K Buy
1,291
+2
+0.2% +$389 0.17% 77
2024
Q4 		$229K Buy
+1,289
New +$237K 0.12% 80

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

M1 Capital Management's ABBV Position: Q2 2026 in Review

M1 Capital Management increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $11.4K and bringing the position to 1,769 shares worth $445K. The position accounts for 0.16% of the portfolio, ranked #74.

M1 Capital Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,233 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • M1 Capital Management held 1,769 shares of AbbVie worth $445K as of Q2 2026.
  • M1 Capital Management bought 53 AbbVie shares in Q2 2026, an estimated $11.4K.
  • AbbVie made up 0.16% of M1 Capital Management's portfolio in Q2 2026, its #74 holding.
  • M1 Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,233 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on M1 Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.